Episode 292 - CELMoDs in Myeloma: A Report From EHA

Chadi is joined by two of the world's leading multiple myeloma experts, Dr. Sagar Lonial of Emory University and Dr. Vincent Rajkumar of Mayo Clinic, for an in-depth discussion of the latest advances in multiple myeloma presented at the European Hematology Association (EHA) Congress in Stockholm. They explore the emerging class of cereblon E3 ligase modulators (CELMoDs), explaining how these next-generation therapies differ from existing immunomodulatory drugs, the science behind their mechanism of action, and why they are generating so much excitement in the field. The conversation also reviews the key clinical trial data unveiled at EHA, discusses where CELMoDs may fit into the evolving treatment landscape, and looks ahead to the breakthroughs that could shape multiple myeloma care in the years to come. Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. https://www.chadinabhan.com/Watch all Healthcare Unfiltered episodes on YouTube. https://www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA